TY - JOUR
T1 - Bacterial biofilm development as a multicellular adaptation
T2 - Antibiotic resistance and new therapeutic strategies
AU - De la Fuente-Núñez, César
AU - Reffuveille, Fany
AU - Fernández, Lucía
AU - Hancock, Robert E.W.
N1 - Funding Information:
The authors would like to apologize for the numerous studies on biofilms that could not be included here given the concise nature of this review article. This work was supported by grants from the National Institutes of Health , Canadian Institutes for Health Research , Cystic Fibrosis Canada . REWH holds a Canada Research Chair in Health and Genomics. CDLF-N received a scholarship from the Fundación ‘la Caixa’ and Fundación Canadá (Spain) .
PY - 2013/10
Y1 - 2013/10
N2 - Bacteria have evolved the ability to form multicellular, surface-adherent communities called biofilms that allow survival in hostile environments. In clinical settings, bacteria are exposed to various sources of stress, including antibiotics, nutrient limitation, anaerobiosis, heat shock, etc., which in turn trigger adaptive responses in bacterial cells. The combination of this and other defense mechanisms results in the formation of highly (adaptively) resistant multicellular structures that are recalcitrant to host immune clearance mechanisms and very difficult to eradicate with the currently available antimicrobial agents, which are generally developed for the eradication of free-swimming (planktonic) bacteria. However, novel strategies that specifically target the biofilm mode of growth have been recently described, thus providing the basis for future anti-biofilm therapy.
AB - Bacteria have evolved the ability to form multicellular, surface-adherent communities called biofilms that allow survival in hostile environments. In clinical settings, bacteria are exposed to various sources of stress, including antibiotics, nutrient limitation, anaerobiosis, heat shock, etc., which in turn trigger adaptive responses in bacterial cells. The combination of this and other defense mechanisms results in the formation of highly (adaptively) resistant multicellular structures that are recalcitrant to host immune clearance mechanisms and very difficult to eradicate with the currently available antimicrobial agents, which are generally developed for the eradication of free-swimming (planktonic) bacteria. However, novel strategies that specifically target the biofilm mode of growth have been recently described, thus providing the basis for future anti-biofilm therapy.
UR - http://www.scopus.com/inward/record.url?scp=84887628130&partnerID=8YFLogxK
U2 - 10.1016/j.mib.2013.06.013
DO - 10.1016/j.mib.2013.06.013
M3 - Review article
C2 - 23880136
AN - SCOPUS:84887628130
SN - 1369-5274
VL - 16
SP - 580
EP - 589
JO - Current Opinion in Microbiology
JF - Current Opinion in Microbiology
IS - 5
ER -